Procoagulant microparticles are increased in patients with Behçet’s disease but do not define a specific subset of clinical manifestations

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Clinical Rheumatology

• Publication date

  2016-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10067-015-2903-4PMID 25711877
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Platelet activation dynamics evaluated using platelet-derived microparticles in Kawasaki disease.

  2014cited by this paper
• Endogenous thrombin potential in Behçet's disease: relationship with thrombosis and anticoagulant therapy.

  2014cited by this paper
• Circulating microparticles: square the circle

  2013cited by this paper
• Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis

  2013cited by this paper
• Behçet's syndrome: a critical digest of the 2012-2013 literature.

  2013cited by this paper
• 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

  2013cited by this paper
• Up-regulation of Th17 and related cytokines in Behçet's disease corresponding to disease activity.

  2013cited by this paper
• Suppression of inflammation reduces endothelial microparticles in active systemic lupus erythematosus

  2013cited by this paper
• Microparticles as mediators and biomarkers of rheumatic disease.

  2012cited by this paper
• Mechanistic View of Risk Factors for Venous Thromboembolism

  2012cited by this paper
• Behçet's syndrome: a critical digest of the recent literature.

  2012cited by this paper
• New insights into the pathogenesis of Behçet's disease.

  2012cited by this paper
• Studies of microparticles in patients with the antiphospholipid syndrome (APS)

  2012cited by this paper
• Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus.

  2011cited by this paper
• Major vessel involvement in Behçet's disease: an update

  2011cited by this paper
• Age, gender and disease-related platelet and neutrophil activation ex vivo in whole blood samples from patients with Behçet's disease.

  2011cited by this paper
• Increased serum concentration of immune cell derived microparticles in polymyositis/dermatomyositis.

  2010cited by this paper
• The role of microparticles in the pathogenesis of rheumatic diseases

  2010cited by this paper
• Etiopathogenesis of Behcet's disease.

  2010cited by this paper
• Mortality in Behçet's disease.

  2010cited by this paper
• MORTALITY IN BEHCETS DISEASE

  2010cited by this paper
• Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity

  2009cited by this paper
• Diagnostic role of endothelial microparticles in vasculitis.

  2008cited by this paper
• Microparticles in health and disease.

  2008cited by this paper
• Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals

  2007cited by this paper
• Allelic Diversity and Affinity Variants of MICA are Imbalanced in Spanish Patients with Behçet's Disease

  2006cited by this paper
• Behçet's disease and hereditary periodic fever syndromes: casual association or causal relationship?

  2005cited by this paper
• D-dimer, P-selectin, and microparticles: Novel markers to predict deep venous thrombosis

  2004cited by this paper
• Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin.

  2002cited by this paper
• Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

  1990cited by this paper
• [Criteria of diagnosis of Behcet's disease].

  1975cited by this paper

• Finding the Needle in the Haystack: Serological and Urinary Biomarkers in Behçet’s Disease: A Systematic Review

  2023cites this paper
• Frail Silk: Is the Hughes-Stovin Syndrome a Behçet Syndrome Subtype with Aneurysm-Involved Gene Variants?

  2023cites this paper
• Recent Advances in Extracellular Vesicles and their involvements in Vasculitis.

  2021cites this paper
• Arterial and Venous Involvement in Behçet’s Disease

  2021cites this paper
• Extracellular vesicles as potential biomarkers and therapeutic approaches in autoimmune diseases

  2020cites this paper
• Current State of Precision Medicine in Primary Systemic Vasculitides

  2019cites this paper
• Extracellular vesicles in autoimmune vasculitis - Little dirts light the fire in blood vessels.

  2019cites this paper
• Procoagulant Effects of Low-Level Platelet Activation and Its Inhibition by Colchicine

  2018cites this paper
• Why are male patients with Behçet's disease prone to thrombosis? A rotational thromboelastographic analysis.

  2018cites this paper
• Microvesicles in Autoimmune Diseases.

  2016cites this paper